Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015 (2015), Article ID 310237, 6 pages
http://dx.doi.org/10.1155/2015/310237
Research Article

Association of 2184AG Polymorphism in the RAGE Gene with Diabetic Nephropathy in Chinese Patients with Type 2 Diabetes

1Department of Endocrinology and Metabolism, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
2Department of Medical Genetics and Cell Biology, Medical College of Nanchang University, Nanchang, Jiangxi 330006, China
3Department of Endocrinology and Metabolism, First People’s Hospital of Xinxiang City, Xinxiang, Henan 453000, China
4Department of Endocrinology and Metabolism, Third Affiliated Hospital of Ganzhou Medical College, Ganzhou, Jiangxi 341000, China

Received 13 August 2015; Accepted 28 September 2015

Academic Editor: Marcus Pezzolesi

Copyright © 2015 Wei Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. Tuttle, G. L. Bakris, R. W. Bilous et al., “Diabetic kidney disease: a report from an ADA Consensus Conference,” American Journal of Kidney Diseases, vol. 64, no. 4, pp. 510–533, 2014. View at Publisher · View at Google Scholar
  2. E. R. Seaquist, F. C. Goetz, S. Rich, and J. Barbosa, “Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy,” The New England Journal of Medicine, vol. 320, no. 18, pp. 1161–1165, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Soulis, V. Thallas, S. Youssef et al., “Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury,” Diabetologia, vol. 40, no. 6, pp. 619–628, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Kaida, K. Fukami, T. Matsui et al., “DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy,” Diabetes, vol. 62, no. 9, pp. 3241–3250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Basta, G. Lazzerini, M. Massaro et al., “Advanced glycation end products activate endothelium through signal transduction receptor RAGE: a mechanism for amplification of inflammatory responses,” Circulation, vol. 105, no. 7, pp. 816–822, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. T. Coughlan, D. R. Thorburn, S. A. Penfold et al., “Rage-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes,” Journal of the American Society of Nephrology, vol. 20, no. 4, pp. 742–752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Reiniger, K. Lau, D. McCalla et al., “Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse,” Diabetes, vol. 59, no. 8, pp. 2043–2054, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. F. Yan, R. Ramasamy, and A. M. Schmidt, “The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature,” Circulation Research, vol. 106, no. 5, pp. 842–853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. B. Manigrasso, J. Juranek, R. Ramasamy, and A. M. Schmidt, “Unlocking the biology of RAGE in diabetic microvascular complications,” Trends in Endocrinology and Metabolism, vol. 25, no. 1, pp. 15–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Kaňková, J. Záhejský, I. Márová et al., “Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM,” Journal of Diabetes and its Complications, vol. 15, no. 4, pp. 185–192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Kaňková, I. Márová, J. Záhejsky et al., “Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status,” Metabolism: Clinical and Experimental, vol. 50, no. 10, pp. 1152–1160, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Levey, J. Coresh, E. Balk et al., “National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” Annals of Internal Medicine, vol. 139, no. 2, pp. 137–147, 2003. View at Publisher · View at Google Scholar
  13. K. Kaňková, A. Stejskalová, L. Pácal et al., “Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach,” Diabetologia, vol. 50, no. 5, pp. 990–999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. X. Ng, U. R. Kuppusamy, I. Tajunisah, K. C. S. Fong, A. C. A. Koay, and K. H. Chua, “2245G/A polymorphism of the receptor for advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malaysian population,” British Journal of Ophthalmology, vol. 96, no. 2, pp. 289–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kaňková, A. Stejskalová, M. Hertlová, and V. Znojil, “Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus,” Nephrology Dialysis Transplantation, vol. 20, pp. 1093–1102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Liu and K. Xiang, “RAGE Gly82Ser polymorphism in diabetic microangiopathy,” Diabetes Care, vol. 22, no. 4, article 646, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Jixiong, X. Bilin, Y. Minggong, and L. Shuqin, “−429T/C and −374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes,” Diabetes Care, vol. 26, no. 9, pp. 2696–2697, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. B. I. Hudson, M. H. Stickland, T. S. Futers, and P. J. Grant, “Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy,” Diabetes, vol. 50, no. 6, pp. 1505–1511, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. X. Ng, U. R. Kuppusamy, I. Tajunisah, K. C. S. Fong, and K. H. Chua, “Association analysis of −429T/C and −374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy,” Diabetes Research and Clinical Practice, vol. 95, no. 3, pp. 372–377, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Kang, C. Tian, and C. Jia, “Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy,” Gene, vol. 500, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Shi, W. Lu, and G. Xie, “Association between the RAGE gene −374T/A, −429T/C polymorphisms and diabetic nephropathy: a meta-analysis,” Renal Failure, vol. 37, no. 5, pp. 751–756, 2015. View at Publisher · View at Google Scholar
  22. A. Z. Kalea, A. M. Schmidt, and B. I. Hudson, “RAGE: a novel biological and genetic marker for vascular disease,” Clinical Science, vol. 116, no. 8, pp. 621–637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Z. Kalea, A. M. Schmidt, and B. I. Hudson, “Alternative splicing of RAGE: roles in biology and disease,” Frontiers in Bioscience, vol. 16, no. 7, pp. 2756–2770, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Yonekura, Y. Yamamoto, S. Sakurai et al., “Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury,” Biochemical Journal, vol. 370, no. 3, pp. 1097–1109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kalousová, M. Jáchymová, M. Oto et al., “Receptor for advanced glycation end products—soluble form and gene polymorphisms in chronic haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 22, no. 7, pp. 2020–2026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Retnakaran, C. A. Cull, K. I. Thorne, A. I. Adler, and R. R. Holman, “Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective diabetes study 74,” Diabetes, vol. 55, no. 6, pp. 1832–1839, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. MacIsaac, C. Tsalamandris, S. Panagiotopoulos, T. J. Smith, K. J. McNeil, and G. Jerums, “Nonalbuminuric renal insufficiency in type 2 diabetes,” Diabetes Care, vol. 27, no. 1, pp. 195–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. National Kidney Foundation, “KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease,” American Journal of Kidney Diseases, vol. 49, no. 2, supplement 2, pp. S12–S154, 2007. View at Publisher · View at Google Scholar
  29. F. He, X. Xia, X. F. Wu, X. Q. Yu, and F. X. Huang, “Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis,” Diabetologia, vol. 56, no. 3, pp. 457–466, 2013. View at Publisher · View at Google Scholar · View at Scopus